Skip to main content
SpringerLink
Log in

Editorial on “Cardiac involvement in cystic fibrosis evaluated using cardiopulmonary magnetic resonance”. Cardiac involvement in cystic fibrosis: more than a lung-related disease?

  • Commentary
  • Published:
The International Journal of Cardiovascular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. De Boeck K (2020) Cystic fibrosis in the year 2020: A disease with a new face. Acta Paediatr Int J Paediatr 109(5):893–899. doi: https://doi.org/10.1111/apa.15155. Epub 2020 Jan 22. PMID: 31899933

    Article  Google Scholar 

  2. Labombarda F, Saloux E, Brouard J, Bergot E, Milliez P (2016) Heart involvement in cystic fibrosis: A specific cystic fibrosis-related myocardial changes? Respir Med 118:31–38. doi: https://doi.org/10.1016/j.rmed.2016.07.011. Epub 2016 Jul 15. PMID: 27578468

    Article  PubMed  Google Scholar 

  3. Jiang K, Jiao S, Vitko M, Darrah R, Flask CA, Hodges CA, Yu X (2016) The impact of Cystic Fibrosis Transmembrane Regulator Disruption on cardiac function and stress response. J Cyst Fibros 15(1):34–42. doi: https://doi.org/10.1016/j.jcf.2015.06.003. Epub 2015 Jun 25. PMID: 26119592; PMCID: PMC4691219

  4. Shah PH, Lee JH, Salvi DJ, Rabbani R, Gavini DR, Hamid P (2021) Cardiovascular System Involvement in Cystic Fibrosis. Cureus 13(7):e16723. doi: https://doi.org/10.7759/cureus.16723. PMID: 34513358; PMCID: PMC8405250

  5. Scully PR, Bastarrika G, Moon JC, Treibel TA (2018) Myocardial Extracellular Volume Quantification by Cardiovascular Magnetic Resonance and Computed Tomography. Curr Cardiol Rep 20(3):15. doi: https://doi.org/10.1007/s11886-018-0961-3. PMID: 29511861; PMCID: PMC5840231

  6. Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, Mascherbauer J, Nezafat R, Salerno M, Schelbert EB, Taylor AJ, Thompson R, Ugander M, van Heeswijk RB, Friedrich MG (2018) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19(1):75. doi: https://doi.org/10.1186/s12968-017-0389-8. Erratum in: J Cardiovasc Magn Reson. Feb 7;20(1):9. PMID: 28992817; PMCID: PMC5633041

  7. Lewis AJM, Rider OJ (2020 Jun) The use of cardiovascular magnetic resonance for the assessment of left ventricular hypertrophy. Cardiovasc Diagn Ther 10(3):568–582. doi: https://doi.org/10.21037/cdt.2020.01.14. PMID: 32695638; PMCID: PMC7369278

  8. Lagan J, Naish JH, Bradley J, Fortune C, Palmer C, Clark D, Schelbert EB, Schmitt M, Bright-Thomas R, Miller CA (2022) Cardiac involvement in cystic fibrosis evaluated using cardiopulmonary magnetic resonance. Int J Cardiovasc Imaging. doi: https://doi.org/10.1007/s10554-021-02496-6. Epub ahead of print. PMID: 34994881

  9. Fraser KL, Tullis DE, Sasson Z, Hyland RH, Thornley KS, Hanly PJ (1999) Pulmonary hypertension and cardiac function in adult cystic fibrosis: role of hypoxemia. Chest 115(5):1321–1328. doi: https://doi.org/10.1378/chest.115.5.1321. PMID: 10334147

  10. Poelaert J, Declerck C, Vogelaers D, Colardyn F, Visser CA (1997) Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 23:553–560. https://doi.org/10.1007/s001340050372. PMID: 9201528

    Article  CAS  PubMed  Google Scholar 

  11. Henno P, Maurey C, Danel C, Bonnette P, Souilamas R, Stern M, Delclaux C, Lévy M (2009) Israël-Biet Pulmonary vascular dysfunction in end-stage cystic fibrosis: role of NF-κB and endothelin-1. Eur Respiratory J Dec 34(6):1329–1337. doi: https://doi.org/10.1183/09031936.00186908. Epub 2009 May 21. PMID: 19460784

    Article  CAS  Google Scholar 

  12. Perrin FM, Serino W (2010) Ischaemic heart disease–a new issue in cystic fibrosis? J R Soc Med 103(Suppl 1):S44–S48. https://doi.org/10.1258/jrsm.2010.s11010. PMID: 20573670; PMCID: PMC2905021

  13. Herrera-Garza EH, Stetson SJ, Cubillos-Garzon A, Vooletich MT, Farmer JA, Torre-Amione G (1999) Tumor necrosis factor-alpha: a mediator of disease progression in the failing human heart. Chest. 115(4):1170–1174. doi: https://doi.org/10.1378/chest.115.4.1170. PMID: 10208224

  14. Berger M (2002) Inflammatory mediators in cystic fibrosis lung disease. Allergy Asthma Proc23(1):19–25. PMID: 11894730

  15. Brilla CG, Rupp H, Funck R, Maisch B (1995) The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure. Eur Heart J 16 Suppl O:107–109. doi: https://doi.org/10.1093/eurheartj/16.suppl_o.107. PMID: 8682074

  16. Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W (2009) Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality. Diabetes Care 1(9):1626–1631. doi: https://doi.org/10.2337/dc09-0586. Epub 2009 Jun 19. PMID: 19542209; PMCID: PMC2732133

Download references

Acknowledgements

none.

Funding

none.

Author information

Authors and Affiliations

  1. National Amyloidosis Centre, University College London, London, United Kingdom

    Ambra Masi MD & Marianna Fontana MD PhD

  2. Royal Free Hospital, London, United Kingdom

    Ambra Masi MD

  3. Department of Cardiovascular Medicine, John Radcliffe Hospital, Oxford, United Kingdom

    Andrew Apps BMBCh PhD

Authors
  1. Ambra Masi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrew Apps BMBCh PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marianna Fontana MD PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ambra Masi MD.

Ethics declarations

Disclosures

the author report no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Masi, A., Apps, A. & Fontana, M. Editorial on “Cardiac involvement in cystic fibrosis evaluated using cardiopulmonary magnetic resonance”. Cardiac involvement in cystic fibrosis: more than a lung-related disease?. Int J Cardiovasc Imaging 38, 1587–1589 (2022). https://doi.org/10.1007/s10554-022-02594-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10554-022-02594-z

Search

Navigation